Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fuji
Queensland Health
Medtronic
Healthtrust
Moodys
Mallinckrodt
Daiichi Sankyo
Julphar

Generated: July 18, 2018

DrugPatentWatch Database Preview

Insulin susp isophane purified pork - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for insulin susp isophane purified pork and what is the scope of insulin susp isophane purified pork freedom to operate?

Insulin susp isophane purified pork
is the generic ingredient in three branded drugs marketed by Novo Nordisk Inc and Lilly, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for insulin susp isophane purified pork.
Summary for insulin susp isophane purified pork
US Patents:0
Tradenames:3
Applicants:2
NDAs:3
Drug Master File Entries: 40
Clinical Trials: 7
DailyMed Link:insulin susp isophane purified pork at DailyMed

US Patents and Regulatory Information for insulin susp isophane purified pork

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc NPH PURIFIED PORK ISOPHANE INSULIN insulin susp isophane purified pork INJECTABLE;INJECTION 018623-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly NPH ILETIN II (PORK) insulin susp isophane purified pork INJECTABLE;INJECTION 018345-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novo Nordisk Inc INSULIN INSULATARD NPH NORDISK insulin susp isophane purified pork INJECTABLE;INJECTION 018194-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKesson
Queensland Health
AstraZeneca
Moodys
Accenture
Express Scripts
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.